Skip to content

Clinical trials

Diabetic Neuropathies trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Neuropathies Country / region: China Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20112
20152
20161
20171
20181
20211
20221
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Unknown status6
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Peking University Third Hospital2
Chongqing Medical University1
Eisai Co., Ltd.1
Fudan University1
Geheng Yuan1
Haisco Pharmaceutical Group Co., Ltd.1
Nanjing First Hospital, Nanjing Medical University1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Neuropathies13
Diabetes Mellitus2
Pain1
Peripheral Nervous System Diseases1
Small Fiber Neuropathy1

Trials

Showing 76 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.